All Episodes

July 15, 2025 63 mins

In this episode, Rachel and Tina dig into the world of clinical trials—what they are, how they work, and why they matter—especially in the rare disease and chronic illness space. To help us separate fact from fiction, we’re joined by two incredible experts who bring decades of experience to the table.

Kerry Biron is a clinical development leader with over 25 years of experience in global clinical operations. She’s helped bring multiple FDA-approved treatments to market, with a focus on rare and orphan diseases. Kerry is also a Spoonie herself, living with Psoriatic Arthritis and Hashimoto’s Thyroiditis.

Nova Silver, RN, MBA, brings over 35 years of experience in clinical development and operations. A former VP of Clinical Operations at Fortress Biotech, Nova has worked across a range of therapies including gene therapy, CAR-T, and small molecule development. Her unique background includes both nursing and teaching mathematics at Harvard.

Whether you’ve considered participating in a trial or are just curious how treatments make it to patients, this conversation will leave you more informed—and maybe even a little inspired.

Find clinical trials at: www.clinicaltrials.gov


This episode is sponsored by Spicey,  Clean heat therapy for every body in pain ❤️‍🔥Find them on Instagram here: https://www.instagram.com/getspicey/

Mark as Played

Advertise With Us

Popular Podcasts

Stuff You Should Know
Dateline NBC

Dateline NBC

Current and classic episodes, featuring compelling true-crime mysteries, powerful documentaries and in-depth investigations. Follow now to get the latest episodes of Dateline NBC completely free, or subscribe to Dateline Premium for ad-free listening and exclusive bonus content: DatelinePremium.com

The Breakfast Club

The Breakfast Club

The World's Most Dangerous Morning Show, The Breakfast Club, With DJ Envy, Jess Hilarious, And Charlamagne Tha God!

Music, radio and podcasts, all free. Listen online or download the iHeart App.

Connect

© 2025 iHeartMedia, Inc.